PB Cosmetic Surgery Limited Filleted accounts for Companies House (small and micro)

PB COSMETIC SURGERY LTD - Company Information

6 false false false false false false false false false true false false false false false false No description of principal activity 2020-02-01 Sage Accounts Production Advanced 2020 - FRS102_2019 100,000 74,167 10,000 84,167 15,833 25,833 201,816 11,807 213,623 101,864 7,708 109,572 104,051 99,952 100 100 100 xbrli:pure xbrli:shares iso4217:GBP 08178274 2020-02-01 2021-01-31 08178274 2021-01-31 08178274 2020-01-31 08178274 2019-02-01 2020-01-31 08178274 2020-01-31 08178274 core:NetGoodwill 2020-02-01 2021-01-31 08178274 bus:Director1 2020-02-01 2021-01-31 08178274 core:NetGoodwill 2020-01-31 08178274 core:NetGoodwill 2021-01-31 08178274 core:WithinOneYear 2021-01-31 08178274 core:WithinOneYear 2020-01-31 08178274 core:AfterOneYear 2021-01-31 08178274 core:ShareCapital 2021-01-31 08178274 core:ShareCapital 2020-01-31 08178274 core:RetainedEarningsAccumulatedLosses 2021-01-31 08178274 core:RetainedEarningsAccumulatedLosses 2020-01-31 08178274 core:NetGoodwill 2020-01-31 08178274 core:CostValuation core:Non-currentFinancialInstruments 2021-01-31 08178274 core:Non-currentFinancialInstruments 2021-01-31 08178274 core:Non-currentFinancialInstruments 2020-01-31 08178274 bus:SmallEntities 2020-02-01 2021-01-31 08178274 bus:AuditExemptWithAccountantsReport 2020-02-01 2021-01-31 08178274 bus:FullAccounts 2020-02-01 2021-01-31 08178274 bus:SmallCompaniesRegimeForAccounts 2020-02-01 2021-01-31 08178274 bus:PrivateLimitedCompanyLtd 2020-02-01 2021-01-31 08178274 core:FurnitureFittingsToolsEquipment 2020-02-01 2021-01-31 08178274 core:FurnitureFittingsToolsEquipment 2020-01-31 08178274 core:FurnitureFittingsToolsEquipment 2021-01-31

COMPANY REGISTRATION NUMBER: 08178274

PB COSMETIC SURGERY LIMITED

FILLETED UNAUDITED FINANCIAL STATEMENTS

31 January 2021

PB COSMETIC SURGERY LIMITED

STATEMENT OF FINANCIAL POSITION

31 January 2021

	2021	2020
Note	£	£

Fixed assets

Intangible assets	5	15,833	25,833
Tangible assets	6	104,051	99,952
Investments	7	100	100
		----------	----------
		119,984	125,885

Current assets

Debtors	8	286,912	358,087
Cash at bank and in hand		397,634	171,544
		----------	----------
		684,546	529,631

Creditors: amounts falling due within one year	9	128,584	108,521
		----------	----------
Net current assets		555,962	421,110
		----------	----------
Total assets less current liabilities		675,946	546,995

Creditors: amounts falling due after more than one year	10	182,000	–

Provisions

Taxation including deferred tax	19,651	18,846
	----------	----------
Net assets	474,295	528,149
	----------	----------

PB COSMETIC SURGERY LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

31 January 2021

	2021	2020
Note	£	£

Capital and reserves

Called up share capital	1	1
Profit and loss account	474,294	528,148
	----------	----------
Shareholders funds	474,295	528,149
	----------	----------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.

For the year ending 31 January 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

These financial statements were approved by the board of directors and authorised for issue on 21 July 2021 , and are signed on behalf of the board by:

Mr P E Banwell
Director

Company registration number: 08178274

PB COSMETIC SURGERY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 JANUARY 2021

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 168 Church Road, Hove, East Sussex, BN2 2DL.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Going concern

No material uncertainties, that may cast significant doubt about the ability of the company to continue as a going concern, have been identified by the director.

The director considers that the uncertainty caused in the cosmetic medical industry as a result of Coronavirus and the restrictions put in place by the government should not materially affect the company's ability to continue as a going concern.

The company has taken advantage of the Covid Business Interruption loan, and the HMRC furlough scheme, as appropriate and will continue to review and monitor costs as the situation develops.

Judgements and key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for services rendered.

Income tax

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Amortisation

Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:

	Goodwill	-	10% straight line

If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.

Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

	Fixtures, fittings & equipment	-	25% reducing balance

Investments

Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.

Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.

Investments in associates

Investments in associates accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in associates accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the associate arising before or after the date of acquisition.

Investments in joint ventures

Investments in jointly controlled entities accounted for in accordance with the cost model are recorded at cost less any accumulated impairment losses. Investments in jointly controlled entities accounted for in accordance with the fair value model are initially recorded at the transaction price. At each reporting date, the investments are measured at fair value, with changes in fair value recognised in other comprehensive income/profit or loss. Where it is impracticable to measure fair value reliably without undue cost or effort, the cost model will be adopted. Dividends and other distributions received from the investment are recognised as income without regard to whether the distributions are from accumulated profits of the joint venture arising before or after the date of acquisition.

Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.

Provisions

Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.

Financial instruments

Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 6 (2020: 7 ).

5. Intangible assets

	Goodwill
	£
Cost
At 1 February 2020 and 31 January 2021	100,000
	----------
Amortisation
At 1 February 2020	74,167
Charge for the year	10,000
	----------
At 31 January 2021	84,167
	----------
Carrying amount
At 31 January 2021	15,833
	----------
At 31 January 2020	25,833
	----------

6. Tangible assets

	Equipment	Total
	£	£
Cost
At 1 February 2020	201,816	201,816
Additions	11,807	11,807
	----------	----------
At 31 January 2021	213,623	213,623
	----------	----------
Depreciation
At 1 February 2020	101,864	101,864
Charge for the year	7,708	7,708
	----------	----------
At 31 January 2021	109,572	109,572
	----------	----------
Carrying amount
At 31 January 2021	104,051	104,051
	----------	----------
At 31 January 2020	99,952	99,952
	----------	----------

7. Investments

	Shares in group undertakings
	£
Cost
At 1 February 2020 and 31 January 2021	100
	----
Impairment
At 1 February 2020 and 31 January 2021	–
	----

Carrying amount
At 31 January 2021	100
	----
At 31 January 2020	100
	----

8. Debtors

	2021	2020
	£	£
Trade debtors	175,432	126,215
Amounts owed by group undertakings and undertakings in which the company has a participating interest	106,684	106,183
Other debtors	4,796	125,689
	----------	----------
	286,912	358,087
	----------	----------

9. Creditors: amounts falling due within one year

	2021	2020
	£	£
Bank loans and overdrafts	28,000	–
Trade creditors	20,785	19,578
Corporation tax	68,944	80,762
Other creditors	10,855	8,181
	----------	----------
	128,584	108,521
	----------	----------

10. Creditors: amounts falling due after more than one year

	2021	2020
	£	£
Bank loans and overdrafts	182,000	–
	----------	----

11.

12. Related party transactions

The company was under the control of Mr P E Banwell throughout the current period. Mr P E Banwell is the sole director and shareholder. No transactions with related parties were undertaken such as are required to be disclosed under FRS 102.